127 related articles for article (PubMed ID: 35595569)
21. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.
Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W
J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
Pedroza-Torres A; Campos-Parra AD; Millan-Catalan O; Loissell-Baltazar YA; Zamudio-Meza H; Cantú de León D; Montalvo-Esquivel G; Isla-Ortiz D; Herrera LA; Ángeles-Zaragoza Ó; Robelo-Romero G; Herrera-Gómez Á; Pérez-Plasencia C
Oncol Rep; 2018 Mar; 39(3):1532-1540. PubMed ID: 29399698
[TBL] [Abstract][Full Text] [Related]
24. Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
Zhang J; Wang L; Jiang J; Qiao Z
Cell Cycle; 2020 Mar; 19(6):652-665. PubMed ID: 32126879
[TBL] [Abstract][Full Text] [Related]
25. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
Che Y; Li Y; Zheng F; Zou K; Li Z; Chen M; Hu S; Tian C; Yu W; Guo W; Luo M; Deng W; Zou L
Cancer Lett; 2019 Jun; 452():1-13. PubMed ID: 30905820
[TBL] [Abstract][Full Text] [Related]
26. Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response.
Bandiera E; Zanotti L; Bignotti E; Romani C; Tassi R; Todeschini P; Tognon G; Ragnoli M; Santin AD; Gion M; Pecorelli S; Ravaggi A
Int J Gynecol Cancer; 2009 Aug; 19(6):1015-21. PubMed ID: 19820362
[TBL] [Abstract][Full Text] [Related]
27. Combination of RIZ1 Overexpression and Radiotherapy Contributes to Apoptosis and DNA Damage of HeLa and SiHa Cervical Cancer Cells.
Yang S; Xing L; Gu L; Cheng H; Feng Y; Zhang Y
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):137-146. PubMed ID: 29575614
[TBL] [Abstract][Full Text] [Related]
28. KLK5, a novel potential suppressor of vaginal carcinogenesis.
Pampalakis G; Zingkou E; Sotiropoulou G
Biol Chem; 2018 Sep; 399(9):1107-1111. PubMed ID: 29561728
[TBL] [Abstract][Full Text] [Related]
29. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
[TBL] [Abstract][Full Text] [Related]
30. Value of Diffusion-Weighted Magnetic Resonance Imaging Combined with miR-18a Level in Predicting Radiosensitivity of Cervical Cancer.
Bu X; Zhang J; Tian F; Wang X; Wu L; Tian W
Med Sci Monit; 2018 Oct; 24():7271-7278. PubMed ID: 30308669
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Jiao X; Zhang S; Jiao J; Zhang T; Qu W; Muloye GM; Kong B; Zhang Q; Cui B
Clin Epigenetics; 2019 Aug; 11(1):120. PubMed ID: 31426855
[TBL] [Abstract][Full Text] [Related]
32. Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.
Oike T; Sekiguchi Y; Yoshimoto Y; Oike T; Ando K; Gu W; Sasaki Y; Tokino T; Iwase A; Ohno T
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008475
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.
Wu Y; Huang J; Xu H; Gong Z
Biomed Pharmacother; 2018 Sep; 105():1325-1334. PubMed ID: 30021370
[TBL] [Abstract][Full Text] [Related]
34. GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level.
Li Q; Wei X; Zhou ZW; Wang SN; Jin H; Chen KJ; Luo J; Westover KD; Wang JM; Wang D; Xu CX; Shan JL
Cell Death Dis; 2018 May; 9(5):524. PubMed ID: 29743554
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy resistance: identifying universal biomarkers for various human cancers.
Larionova I; Rakina M; Ivanyuk E; Trushchuk Y; Chernyshova A; Denisov E
J Cancer Res Clin Oncol; 2022 May; 148(5):1015-1031. PubMed ID: 35113235
[TBL] [Abstract][Full Text] [Related]
36. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
Song L; Liu S; Zeng S; Zhang L; Li X
Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
[TBL] [Abstract][Full Text] [Related]
37. miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.
Wang X; Li Q; Jin H; Zou H; Xia W; Dai N; Dai XY; Wang D; Xu CX; Qing Y
Oncotarget; 2016 Nov; 7(47):77508-77515. PubMed ID: 27769049
[TBL] [Abstract][Full Text] [Related]
38. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.
Korbakis D; Gregorakis AK; Scorilas A
Clin Chem; 2009 May; 55(5):904-13. PubMed ID: 19299547
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
